Vascular Biology |
From the Department of Laboratory Medicine (S.N., T.N., J.M.), Central Clinical Laboratory (H.S., H.M.), and the Third Department of Internal Medicine (K.Y., S.K.), Shimane Medical University, and the Shimane Institute of Health Science (T.N., K.Y., S.K.), Izumo, Japan.
Correspondence to Toru Nabika, MD, Department of Laboratory Medicine, Shimane Medical University, Izumo 693, Japan. E-mail nabika{at}shimane-med.ac.jp
Effects of smoking on white matter lesions, such as lacunar infarction and leukoaraiosis, are still controversial. We hypothesized that the endothelial NO synthase (eNOS) genotype was a modulating factor for the effect of smoking on cerebral circulation. We took a cross-sectional population from the participants of a health examination to study the effects of smoking and a single-nucleotide polymorphism in the eNOS gene, T-786C. Smokers and nonsmokers were defined as having a smoking index (cigarettes per day times years) of
200 and 0, respectively. One hundred sixty-six male nonsmokers and 344 male smokers were recruited. Cerebral blood flow was measured by the 133Xe inhalation method. Genotyping of T-786C was performed by using a newly developed allele-specific polymerase chain reaction. Smokers were exposed to greater oxidative stress, as estimated by urinary F2-isoprostane excretion. In smokers, CC homozygotes of T-786C showed a significant decrease of cerebral blood flow (56.6±13.3, 57.6±11.5, and 44.0±7.2 mL/min per 100 g tissue for TT, TC, and CC, respectively; P=0.03 by ANOVA) and a significant increase of cerebrovascular resistance, whereas the eNOS genotype did not affect these parameters in nonsmokers. This result indicated that the eNOS genotype could modify cerebrovascular circulation in a general population by potentiating the adverse effect of smoking.
Key Words: nitric oxide synthase polymorphism cross-sectional studies cerebral circulation
This article has been cited by other articles:
![]() |
J. P. Casas, G. L. Cavalleri, L. E. Bautista, L. Smeeth, S. E. Humphries, and A. D. Hingorani Endothelial Nitric Oxide Synthase Gene Polymorphisms and Cardiovascular Disease: A HuGE Review Am. J. Epidemiol., November 15, 2006; 164(10): 921 - 935. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. F. Luscher and R. Corti Flow: The Signal of Life Circ. Res., October 15, 2004; 95(8): 749 - 751. [Full Text] [PDF] |
||||
![]() |
S. Erbs, Y. Baither, A. Linke, V. Adams, Y. Shu, K. Lenk, S. Gielen, R. Dilz, G. Schuler, and R. Hambrecht Promoter but Not Exon 7 Polymorphism of Endothelial Nitric Oxide Synthase Affects Training-Induced Correction of Endothelial Dysfunction Arterioscler Thromb Vasc Biol, October 1, 2003; 23(10): 1814 - 1819. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Loscalzo Functional polymorphisms in a candidate gene for atherothrombosis: Unraveling the complex fabric of a polygenic phenotype J. Am. Coll. Cardiol., March 19, 2003; 41(6): 946 - 948. [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |